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Characterization and taste masking evaluation of microparticles 
with cetirizine dihydrochloride and methacrylate-based 
copolymer obtained by spray drying
Taste of a pharmaceutical formulation is an important pa-
rameter for the effectiveness of pharmacotherapy. Cetiri-
zine dihydrochloride (CET) is a second-generation antihis-
tamine that is commonly administered in allergy treatment. 
CET is characterized by extremely bitter taste and it is a 
great challenge to successfully mask its taste; therefore the 
goal of this work was to formulate and characterize the mi-
croparticles obtained by the spray drying method with 
CET and poly(butyl methacrylate-co-(2-dimethylamino-
ethyl) methacrylate-co-methyl methacrylate 1:2:1 copoly-
mer (Eudragit E PO) as a barrier coating. Assessment of 
taste masking by the electronic tongue has revealed that 
designed formulations created an effective taste masking 
barrier. Taste masking effect was also confirmed by the in 
vivo model and the in vitro release profile of CET. Obtained 
data have shown that microparticles with a drug/polymer 
ratio (0.5:1) are promising CET carriers with efficient taste 
masking potential and might be further used in designing 
orodispersible dosage forms with CET.
Keywords: taste masking, electronic tongue, cetirizine dihy-
drochloride, microparticles, methacrylate copolymer, spray 
drying
Unacceptable taste is an important problem encountered in the designing of new dos-
age forms. Taste masking of drug substances has been continuously changing with emerg-
ing techniques and new excipients (1–7). Taste masking can be carried out by various 
methods, depending on the therapeutic agent and dosage form. One of the simplest taste 
masking methods is addition of flavors, sweeteners and effervescent agents, but it is not 
always effective. In recent years, methods creating a physical barrier between active ingre-
dients and taste buds have been developed for taste masking. One of them is spray drying, 
a relatively simple and convenient technology for the preparation of microparticles (8–11). 
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poly(butyl methacrylate-co-(2-dimethylaminoethyl) methacrylate-co-methyl methacrylate 
1:2:1 copolymer with pH dependent solubility. It is insoluble in saliva (pH 6.8–7.2) and dis-
solves quickly under salt formation at pH values below 5, which ensures effective protec-
tion in the mouth and fast drug release in the stomach. Another major benefit of this 
polymer is its combining taste masking with moisture protection (7).
Cetirizine dihydrochloride (CET) is a commonly used antihistaminic drug in the 
treatment of allergies, hay fever or urticaria (12). CET is applied as a model drug because 
its extremely bitter taste hinders formulation of orodispersible dosage forms, in which ef-
ficient taste masking effect is necessary. Various methods for masking CET bitter taste have 
been reported, such as: complexation with cyclodextrins and ion exchange resins (13–15), 
hot-melt extrusion (16) or fluidized bed coating (17). Another approach to mask the bitter 
taste of drugs is the use of taste masking polymers; therefore the goal of this work was to 
formulate and characterize the microparticles obtained by the spray drying method with 
CET and Eudragit E PO as coating substances. Microparticles are solid, spherical particles 
with the diameter size ranging from 1 µm to 500 µm. An important stage in designing 
microparticles is selection of an appropriate polymeric material as the drug agent carrier, 
since its physicochemical properties are crucial factors in the final product performance (9, 
10, 18).
In order to determine whether the designed microparticles effectively mask CET taste, 
a human taste panel, in vitro CET release and the electronic taste sensing system (elec-
tronic tongue) were used. Electronic tongue receives information from chemicals through 
an electrode array, which works in a process similar to human receptors (19–21). Influence 
of the drug/polymer ratio and concentration of polymer solution on the characteristics of 
prepared microparticles was also studied.
EXPERIMENTAL
Materials
Acrylates/dimethylaminoethyl methacrylate copolymer (Eudragit E PO), stearic acid 
and sodium dodecyl sulfate were obtained from Evonik Industry (Germany). Talc was a 
product of Amara (Poland). Cetirizine dihydrochloride (CET) was a gift from ZF Polfa S.A. 
(Poland). Bis-(2-ethylohexal) sebacate (DOS), 2-nitrophenyl octyl ether (o-NPOE), liophilic 
salts: potassium tetrakis -(pentafluorophenyl)-borate (KTPC1PB), potassium tetrakis-[3,5-
bis-(trifluoromethyl)-phentyl]-boranate (KTFPB), tridodecylmethylammonium (TDMAC), 
high-molecular-weight polyvinyl chloride (PVC), ionophores: calcium (ETH 129), ammo-
nium (ETH 6010), tridodecylamine, amine and sodium were obtained from Sigma-Aldrich 
Chemie Gmbh (Germany).
Preparation of microparticles
Microparticles were obtained by spray drying using a Mini Spray Dryer B-290 (Büchi 
Labortechnik AG, Switzerland) equipped with a standard 0.7 mm nozzle. In order to set 
optimal parameters of the spray drying process to obtain the product of desired proper-
ties, a number of preliminary tests were conducted and experimental parameters were 
chosen. Experiments were carried out under the following conditions: inlet temperature 
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47 °C, aspirator flow 97 %, feed flow 2 mL min–1, spray flow 600 L h–1. Various drug/poly-
mer ratios (0.5:1, 1:1, 1.5:1) and different polymer concentrations (5 and 10 %) were used for 
microparticle formulation. Talc was used as filler and sodium dodecyl sulfate as surfac-
tant. Stearic acid was added to form a salt with Eudragit E PO. Water solution (95:5, V/V) 
with addition of 0.1 mol L–1 hydrochloric acid as polymer solvent was used. CET was dis-
solved in the polymer solution.
Evaluation of microparticles
Size and morphology analysis. – Measurements of the particle size and mean diameter 
were performed using an optical microscope (Motic Deutschland GmbH, Germany). 
Morphology of CET and the obtained microparticles was assessed under a scanning elec-
tron microscope (SEM) (S-400, Hitachi, Japan). Before SEM imaging, microparticles were 
sputter-coated with gold.
HPLC analysis. – The amount of CET was examined using the HPLC system Agilent 
Technologies 1200 and Zorbax Eclipse XDB–C18, 4.6×150 mm, 5 µm column (Agilent Tech-
nologies, Germany). Data collection and analysis were conducted with Chemstation 6.0 
software. Acetonitrile/water solution (40:60, V/V) with addition of 0.1 mol L–1 triethylamine 
(pH 3.5) was used as the mobile phase. The flow rate was 1.0 mL min–1 and ultraviolet de-
tection was done at 215 nm (22, 23). CET retention time was 3.5 min. Standard calibration 
curve was linear over the range of 1–100 µg/mL with the correlation coefficient R2 = 0.999. 
The studies were carried out in triplicate.
Determination of CET loading, encapsulation efficiency and production yield. – To determine 
CET loading, an accurately weighed amount of microparticles (10 mg) was dissolved in 10 
mL 0.1 mol L–1 HCl and agitated for 1 h, at 150 rpm, in a water bath. After filtration through 
0.45 µm cellulose acetate filters (Millipore, USA), CET concentration was analyzed by the 
HPLC method as described in point HPLC analysis. Mean drug encapsulation efficiency 
was computed using the equation:
 EE = Qa /Qt × 100  (1)
where EE is percent of encapsulation efficiency, Qa actual drug content and Qt theoretical 
drug content.
The percent yield of CET in microparticles was determined using the formula:
 Y = mm /mt × 100  (2)
where Y is percent production yield, mm mass of microparticles and mt theoretical mass of 
the drug and polymer.
Percent of CET loading in microparticles was determined using the equation:
 L = Qm /mm × 100  (3)
where L is percent of CET loading, Qm drug loaded in the microparticles and mm mass of 
the microparticles (24). The studies were carried out in triplicate.
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Moisture content. – Moisture content in microparticles was assessed using a moisture 
analyzer balance (Radwag, Poland). Each formulation was analyzed in triplicate.
Taste masking evaluation by the electronic tongue. – The potentiometric electronic tongue 
that was applied in this study was based on 16 potentiometric standard ion-selective elec-
trodes (ISEs): 12 cation-selective and 4 anion-selective (Fig. 1). They were equipped with 
polyvinyl chloride (PVC) membranes with various electroactive additives for differenti-
ated selectivity (Table I). Preparation of the membranes and electrode conditioning was 
the same as for the standard (ISEs). As a reference, a standard double junction Ag/AgCl 
electrode was used. This sensor array was used for static (batch) measurements of electro-
motive force with a potentiometric multiplexer (EMF 16 Interface, Lawson Labs Inc., USA). 
Before measuring microparticles, all sensors were qualified on the basis of their response 
repeatability and adequate sensitivity. For this study, 10 types of samples were considered: 
reference solution (reference electrolyte 0.0001 mol L–1 Ca(NO3)2, 0.0001 mol L–1 NaCl), pure 
CET, pure Eudragit E PO, Eudragit E PO microparticle placebo and the obtained micropar-
ticle formulations F1–F6 with Eudragit E PO and CET. Each sample was placed in 100 mL 
of deionized water; measurement time was 7 min with signal acquisition every 5 s. Final 
output of the array was based on 10 last readings for each sensor. Samples were measured 
in triplicate; therefore the final data matrix to be analyzed was 300 × 16 (samples x vari-
ables). Data were processed with the aid of Principal Component Analysis (PCA), prior to 
which autoscaling was applied. Each sample was analyzed in triplicate. Calculations and 
data analysis were conducted using MatLab (The MathWorks, Inc., USA) and Origin (Mi-
crocal Software, Inc, USA) software.
Fig. 1. Electronic tongue set-up: sensor array (A) with a sample (B), signal acquisition by a potentio-
metric multi-channel potentiometer (C) with L-EMF DAQ software (D), data analysis system (E).
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In vitro drug release. – To determine CET release profiles, a USP dissolution apparatus 
type II (Erweka GmbH, Germany) was used. All formulations of microparticles (in an 
amount corresponding to 10 mg of CET) were suspended in 750 mL of phosphate buffer 
(pH 6.8) and stirred at 75 rpm at 37 ± 1 °C. As CET is freely soluble in water, the sink condi-
tion was achieved during the dissolution test. At predetermined time intervals, samples 
were withdrawn and replaced with fresh medium. Concentration of CET was analyzed 
using the HPLC method as described in the point HPLC analysis. Each formulation was 
analyzed in triplicate.
Human taste panel. – The study was performed in a group of 6 selected healthy volun-
teers (Research Ethics Committee, Medical University of Białystok, approval number R-I-
002/262/2014). Before the test, the mouth was flushed with purified water and then a por-
Table I. Components used for sensor preparationa
Electrode type Plasticizer Lipophilic salt Ionophore Internal filling/conditioning solution (conc. in mol L–1)
CA-1
CA-2
DOS KTPClPB ETH 129 CaCl2 (0.01/0.001)
AM-1
AM-2
DOS – Amine ionophore I KCl (0.01/0.001)
AMON-1
AMON-2
DOS – Nonactin NH4Cl (0.01/0.001)
NA-1
NA-2





















DOS KTFPB – KCl (0.01/0.001)
AS-1
AS-2
o-NPOE TDMAC – NaCl (0.01/0.001)
a Description of components is given in Experimental section
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tion of microparticles corresponding to 10 mg of CET loading was placed on the tongue for 
30 s. After this time, the oral cavity was rinsed with purified water again. To evaluate the 
taste, a scale with the following numerical values was used: 0 – not bitter; 1 – slightly bitter; 
2 – moderately bitter and 3 – very bitter. Each formulation was analyzed in triplicate. Before 
the test, taste threshold evaluation was performed in 20 probands under blind conditions 
using a series of solutions of substances representing basic tastes: sour (tartaric acid), sweet 
(sucrose), salty (sodium chloride) and bitter (quinine hydrochloride). Each proband tasted 
some coded samples from each series with increasing concentrations of standard sub-
stances. Before the test and at the end of each quality test, assessors rinsed out their mouths 
with distilled water. The participants had to correctly recognize the tastant in each series. 
The lowest concentration correctly named was taken as the detection threshold (25). For 
further studies, only 6 volunteers with the highest taste recognition ability were selected.
Statistical analysis
Quantity variables were expressed as the mean and standard deviation. Statistical 
analysis was performed using the STATISTICA 10.0 software.
RESULTS AND DISCUSSION
Characterization of microparticles obtained with CET and Eudragit E PO
In the last few years, encapsulation of drug substances with bitter taste into polymer 
microparticles has been considered an efficient taste masking method. Polymer matrix 
creates a physical barrier, which prevents contact of the drug with the patients’ gustatory 
bulbs. Eudragit E PO was used as a taste masking agent because it does not dissolve in the 
buccal cavity, thus keeping the incorporated drug intact, and ensures instant release of the 
active ingredient in the acidic pH in the stomach (7). Characteristics of microparticles 
formulated using the spray drying method are given in Table II.
Table II. Characteristics of microparticle formulations F1-F6 obtained with different concentrations of 















5 % Polymer solution
F1 0.5:1 44.8 ± 3.5 12.0 ± 2.1 52.0 ± 3.2 4.9 ± 2.7 1.3 ± 0.5
F2 1:1 52.9 ± 2.7 13.0 ± 1.2 58.9 ± 2.2 5.4 ± 1.8 1.1 ± 0.7
F3 1.5:1 68.5 ± 2.1 18.5 ± 1.2 68.4 ± 3.1 6.6 ± 2.1 1.0 ± 0.4
10 % Polymer solution
F4 0.5:1 42.7 ± 3.2 12.3 ± 1.2 57.1 ± 2.1 4.7 ± 3.6 1.1 ± 0.9
F5 1:1 60.0 ± 2.1 10.1 ± 1.2 62.8 ± 2.0 5.9 ± 3.3 1.0 ± 0.2
F6 1.5:1 72.2 ± 2.8 10.0 ± 1.0 71.1 ± 3.7 8.6 ± 2.1 0.8 ± 0.5
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Comparison of particle sizes indicated that higher drug/polymer ratios resulted in 
larger particle sizes. Formulation F4 with the lowest CET loading (42.7 %) has the mean 
diameter of 4.7 µm, and formulation F6 with the highest CET loading (72.2 %), about 8.6 
µm. The drug/polymer ratio also affects the encapsulation efficiency and CET loading. In 
microparticles with the highest drug/polymer ratio (F3, F6), both parameters were in-
creased. In microparticles with 5 % of polymer solution, encapsulation efficiency increased 
from 52.0 to 68.4 % and in microparticles with 10 % of polymer from 57.1 to 71.1 %. Water 
content in all formulations of microparticles obtained with both polymer concentrations 
was similar and was in the range 0.8–1.3 %. Interestingly, polymer concentration (5 or 10 
%) did not affect CET loading essentially, but influenced the production yield. The lowest 
production yield was observed with 10 % polymer solution and 1.5:1 drug/polymer ratio 
(formulation F6). Properties of the microparticles obtained with the spray drying tech-
nique do not depend only on the drying parameters such as: inlet temperature, aspirator 
flow, feed flow and spray flow but also on the properties of the mixture subjected to dry-
ing. The higher the concentration of the components, the higher is the density and the 
lower the yield (26–28). When using methacrylate copolymers to obtain microparticles by 
the spray drying method, a low yield of the process is often observed. Sipos et al. noted the 
relationship between increased viscosity of the dried solution of ammonium methacrylate 
copolymer and lower yield (29). Mane et al. proposed other reasons for low efficiency of the 
spray drying process: the design of the cyclone separator, which is unable to trap particles 
below 2 µm diameter, and adhesion of the particles to the inner wall of the spray dryer 
(30). Moreover, Kulkarni et al. suggested that low yield might be a result of electrostatic 
interactions between powder particles and glass walls of the drying chamber (31).
To assess surface morphology, the obtained microparticles were observed using scan-
ning electron microscopy. All formulated microparticles were spherical in shape and had 
a smooth surface (data not shown). Representative SEM micrographs of pure CET and the 
CET microparticle formulation F4 (with the lowest CET loading) are given in Fig. 2.
Taste masking evaluation of microparticles obtained with CET and Eudragit E PO
An extremely important issue is to precisely and repeatedly assess the taste masking 
effectiveness; therefore in this study the taste evaluation of designed microparticles was 
performed by three independent methods: electronic tongue (Fig. 1), in vitro CET release 
and human taste panel (test in healthy volunteers).
The potentiometric electronic tongue applied in this study was based on 16 potentio-
metric standard ion-selective electrodes (ISEs) of various cross-selectivity according to the 
Fig. 2. SEM images: a) pure CET under magnification 10 000×, b) microparticle formulation F4 under 
magnification 10 000×, c) microparticle formulation F4 under magnification 20 000 x.
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different electroactive additives used (Table I). Such a device was utilized previously for 
the studies of different samples: discrimination between various formulations based on 
caffeine citrate (19), microencapsulated ibuprofen and roxithromycin (20, 21, 32) and for the 
analysis of acetaminophen, ascorbic acid and acetylsalicylic acid in a mixture (33). Final 
chemical images for appropriate time points were presented on 2D-PCA plots (Figs. 3a-c). 
Firstly, it must be noted that distinctive clusters for all these plots are easily observable. 
They are formed by chemical images of samples of various types, which show appropriate 
classification accuracy of the electronic tongue used in this study. Secondly, formulations 
F1–F6 are easily discernable from both pure CET and placebo samples, showing the mask-
ing effect obtained with the use of Eudragit E PO. And finally, the structure of clusters is 
similar in the 2nd, 5th and 7th minute of the measurement (very similar arrangement of 
clusters in Figs. 3d-f).
In the second part of this study, a more detailed investigation of the chemical images 
of 6 types of Eudragit E PO–based microparticles containing CET was performed. Data 
matrix 180 × 16 in size was processed with the aid of PCA; respective 2D–PCA plots for the 
2nd, 5the and 7th minute of the measurement are given in Figs. 3d-f. Again, similar ar-
rangement of the clusters was observable regardless of the time point. In this case, how-
ever, some formulations showed high similarity and some can be easily differentiated. The 
most distinct are microparticle formulations F1 and F4 (5 % concentration of polymer, 0.5:1 
Fig. 3. Principal Component Analysis (PCA) plots showing taste clusters of the reference solution, 
pure CET, Eudragit E PO, microparticle placebo and microparticle formulations F1-F6 at distinct 
time-points of dissolution process: a) all samples after 2 min, b) all samples after 5 min, c) all samples 
after 7 min, d) microparticle formulations F1-F6 after 2 min, e) microparticle formulations F1-F6 after 
5 min, f) microparticle formulations F1-F6 after 7 min.
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drug/polymer ratio and 10 % polymer concentration, 0.5:1 drug/polymer ratio). Higher 
polymer to drug ratio influenced higher similarity of the chemical images of respective 
formulations. In the case where the highest amount of CET was present in the micropar-
ticles (formulations F3 and F6), chemical images became almost the same – the clusters are 
not separable in the PC1–PC2 space. Masking effect is visible when distinct clusters are 
observed on the PCA score plot and this is the case in point (all formulation clusters are 
linearly separable from points representing pure drug; therefore the electronic tongue can 
see the difference between pure CET and CET microencapsulates). The first two principal 
components explain about 90 % of variance in each case of the analysis.
Taste masking effectiveness was also evaluated by the in vitro CET release from de-
signed microparticles. The in vitro release was carried out in phosphate buffer pH 6.8 (cor-
responding to saliva pH) (34). CET release profiles from microparticle formulations F1–F6 
are shown in Fig. 4. In all formulations, no CET release was observed up to 3 min and 100 
% of CET was released after about 15 min.
Fig. 4. In vitro CET release from microparticle formulations F1–F6 in phosphate buffer (pH 6.8).
Table III. Sensory evaluation of microparticle formulations F1-F6
Scorea
Volunteer F1 F2 F3 F4 F5 F6
1 0 2 1 0 1 2
2 1 1 1 0 1 1
3 0 2 2 1 1 1
4 0 2 2 0 1 2
5 1 2 1 1 2 1
6 0 1 1 0 1 2
a Scored as follows: 0 – not bitter, 1 – slightly bitter, 2 – moderately bitter, 3 – very bitter.
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Taste masking efficiency of microparticles formulated with Eudragit E PO was addi-
tionally examined by 6 healthy volunteers. Organoleptic analysis of microparticles re-
vealed that none of the tested formulations possessed intense bitter taste – no proband 
specified the microparticles as „very bitter“, only few individuals identified the taste as 
moderately bitter, while the vast majority defined their taste as not bitter or slightly bitter 
(Table III). Moreover, the probands did not report the feeling of „spicy“ or other unpleasant 
organoleptic sensations such as „burning tongue”. The in vivo assessment confirmed the 
results obtained from the electronic tongue. Formulations F1 and F4 (with the lowest CET 
loading) were characterized by the highest taste masking potential and created the most 
effective barrier. All volunteers assessed these formulations as not bitter or only slightly 
bitter (Table III).
CONCLUSIONS
In conclusion, three independent assessment methods for taste masking effectiveness: 
electronic tongue, in vitro CET release, and human taste panel revealed that Eudragit E PO 
with an appropriate drug/polymer ratio created an efficient taste masking barrier. Eudragit 
E PO can be recommended as an excipient for CET taste masking by the spray drying 
method and designed microparticles can be effectively used for further studies of orodis-
persible formulations with CET. Preparation and evaluation of orodispersible dosage 
forms (orally disintegrating tablets and oral lyophilisates) is in progress and will be de-
scribed in due course.
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